** August 13th BioWorkshop. Prepare for partnering / licensing with big Pharma. Sponsored by CSL, GSK & Wyeth. Hosted by Clayton Utz

Click here for registration form

Objective

To provide biotech managers with a clear strategic understanding of each company's therapy focus and the level of the preparation that is required to seriously discuss focussed partnering / licensing  opportunities with big pharma.

Pharma partnering and therapy area presentations (CSL, GSK, Wyeth) 3 x 30 mins sessions. 9.00 am – 10.30 am

Dr Tony Eglezos, Director of Commercial Development R&D, CSL Ltd

Dr Ashley Bates, Head R&D Alliances Australia/NZ, GSK Australia Ltd

Mr Michael Nobes, Director Corporate Affairs & Health Strategy, Wyeth Australia Pty Ltd.

Global trends and company focus

Therapy areas of interest

How does the company’s partnering strategy work?

• how does the pharma look for opportunities?
• how do the business development teams work?
• what will maximise your probability of success?
• who are the key contacts?

Business Planning and end user / prescriber forecasting

Biologics strategy / approach

Facilitated Pharma Panel Session (CSL, GSK, Wyeth) 11.00 am – 12.00 pm

Dr Tony Eglezos,CL Ltd, Dr Ashley Bates GSK Australia Ltd, Mr Paul Cunningham, Wyeth Australia Pty Ltd

Internal vs external R&D

Therapy areas and trends

• Emerging technologies & opportunities
• Enabling technologies & opportunities
• Platform technologies

Clinical development trends

Business planning

Developments in Asia Pacific and opportunity trends

Deal trends

• structured risk management
• ‘backloading’ deals vs ‘up front’ payments

Facilitated biotech panel discussion – key success factors in licensing / partnering 12.00 pm - 12.40 pm

Dr Roland Scollay, CEO, Metabolic Pharmaceuticals and Dr Rob Crombie, Vice President - Business Development, Arana Therapeutics Ltd.

Brief observations about success factors in the partnering process

• “Warming up” potential partners prior to an important result coming out
• Putting the data package into pharma language if possible – ticking their boxes
• No nonsense, point out the weaknesses before they find them
• Keep deals simple as possible
• Managing your lawyers – demand plain English, and crystal clarity
• Realistic time frames, realistically 6-18 months – already covered in the pharma presentations.
• Effort and resources to manage and maintain the alliance – a big deal if the biotech continues to be involved in the development.

Don’t miss this chance to hear from big pharma about the latest developments in therapy areas of interest and how to prepare for a licensing a deal.

Time: from 8:45 am for 9 am start.

Conclusion: 12:30 pm, followed by a light luncheon.

Venue: Level 18, 333 Collins St. Melbourne VIC  3000

Price (incl GST): Members $250 per person. Non members $800 per person.

RSVP DEADLINE - By 5 pm, Wednesday August 6th 2008.

NOTE: Speakers and topics may change without notice.

Due to the popularity of our BioWorkshops, Network Members have priority.

Shane Hickey, email: shickey@biomelbourne.org, tel: 9650 8800